Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dishman Pharmaceuticals And Chemicals Ltd Announces Appointment Of Chief Executive Officer


Wednesday, 3 Jul 2013 06:26am EDT 

Dishman Pharmaceuticals and Chemicals Ltd announced that Mr. Mark Griffiths has been appointed as CEO of Dishman Group of Companies, worldwide. 

Company Quote

160.6
-1.25 -0.77%
6:26am EDT